Cushing's syndrome resulting from either a pituitary or adrenal lesion
is a relatively rare entity. A class of patients, characterized by ab
normal biochemical regulation of the hypothalamo-pituitary-adrenal axi
s but no clinical manifestation of adrenal hyperfunction, has been des
cribed. This condition has been labeled subclinical or preclinical Cus
hing's syndrome. The optimal evaluation and treatment of this syndrome
are unclear. The clinical epidemiology of Cushing's syndrome and its
relationship to the subclinical and preclinical states are discussed a
nd are used to suggest possible diagnostic and therapeutic strategies.